Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 243

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 243
---
 otherwise dispose of any or all of their shares on any stock exchange, market, or trading facility on
which the shares are traded or in private transactions, using the following methods:

| ● | ordinary brokerage transactions                                  
 and transactions in which the broker-dealer solicits purchasers; |

| ● | block trades in which the                                                                                                                
 broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate 
 the transaction;                                                                                                                         |

| ● | purchases by a broker-dealer                                  
 as principal and resale by the broker-dealer for its account; |

| ● | an exchange distribution                                 
 in accordance with the rules of the applicable exchange; |

| ● | privately negotiated transactions; |

| ● | settlement of short sales; |

| ● | in transactions through                                                                                                                   
 broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security; |

| ● | through the writing or                                                                                 
 settlement of options or other hedging transactions, whether through an options exchange or otherwise; |

| ● | a combination of any such 
 methods of sale; or       |

| ● | any other method permitted  
 pursuant to applicable law. |

The Selling Stockholders are currently not permitted
to sell securities under Rule 144 under the Securities Act, but may sell them later, if and when Rule 144 will be available, rather than
selling under this Prospectus.

Broker-dealers engaged by the Selling Stockholders
may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders
(or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except
as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission
in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

The Selling Stockholders and any broker-dealers
or agents that are involved in selling the securities may be deemed to be “underwriters” within the meaning of the Securities
Act in connection with such sales. In such an event, any commissions received by such broker-dealers or agents and any profit on the
resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The